Characterization of the anti-angiogenic and anti-vascular effects of bevacizumab using mathematical tools: an effective way to determine the normalization window? - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2014

Characterization of the anti-angiogenic and anti-vascular effects of bevacizumab using mathematical tools: an effective way to determine the normalization window?

Domaines

Cancer
Fichier non déposé

Dates et versions

hal-01074704 , version 1 (15-10-2014)

Identifiants

  • HAL Id : hal-01074704 , version 1

Citer

Karima El Alaoui Lasmaili, Jean-Baptiste Tylcz, El-Hadi Djermoune, Noémie Thomas, Béatrice Faivre. Characterization of the anti-angiogenic and anti-vascular effects of bevacizumab using mathematical tools: an effective way to determine the normalization window?. 5ème Congrès de la Société Française d'Angiogenèse, Apr 2014, Chamonix, France. ⟨hal-01074704⟩
42 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More